Financhill
Back

Mackenzie Emerging Markets Equity Index ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
50

QEE.TO
Mackenzie Emerging Markets Equity Index ETF

Last Price:
$116.76
Seasonality Move:
2.21%
Buy
64

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$90.20
Seasonality Move:
-30.03%
Sell
50
Mackenzie Emerging Markets Equity Index ETF (QEE.TO) is a Sell

Is Mackenzie Emerging Markets Equity Index ETF a Buy, Sell or Hold?

  • The current Mackenzie Emerging Markets Equity Index ETF [QEE.TO] share price is $116.76. The Score for QEE.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • QEE.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QEE.TO Stock Price Chart

What is Mackenzie Emerging Markets Equity Index ETF's stock price today?

  • The Mackenzie Emerging Markets Equity Index ETF share price today is $116.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QEE.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $93.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

QEE.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 33.47 Sell
Chaikin Money Flow: 621 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 147064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.66 - 81.44) Buy
Bollinger Bands (100): (40.97 - 68.09) Buy

QEE.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.81 Sell
20-day SMA: 119.38 Sell
50-day SMA: 120.44 Sell
200-day SMA: 107.85 Buy
8-day EMA: 118.5 Sell
20-day EMA: 119.36 Sell
50-day EMA: 119 Sell
200-day EMA: 110.33 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.53 Buy
20-day SMA: 72.88 Buy
50-day SMA: 64.83 Buy
200-day SMA: 42.54 Buy
8-day EMA: 84.37 Buy
20-day EMA: 75.93 Buy
50-day EMA: 66.06 Buy
200-day EMA: 46.89 Buy

Mackenzie Emerging Markets Equity Index ETF Earnings Growth & QEE.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Mackenzie Emerging Markets Equity Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):